Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
Jasper Therapeutics (JSPR) Stock Price & Analysis
338 Followers
JSPR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.00 - $31.01
Previous Close$26.3
Volume87.14K
Average Volume (3M)132.19K
Market Cap
$396.18M
Enterprise Value$295.33M
Total Cash (Recent Filing)$103.87M
Total Debt (Recent Filing)$3.01M
Price to Earnings (P/E)-4.2
Beta2.34
Next Earnings
May 10, 2024EPS Estimate
-$1.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.19
Shares Outstanding15,063,896
10 Day Avg. Volume68,198
30 Day Avg. Volume132,186
Standard Deviation0.42
R-Squared0.09
Alpha0.00060
Financial Highlights & Ratios
Price to Book (P/B)4.44
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-43.43
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-20.88
Forecast
1Y Price Target
$67.50Price Target Upside179.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Jasper Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
JSPR FAQ
What was Jasper Therapeutics’s price range in the past 12 months?
Jasper Therapeutics lowest stock price was $4.00 and its highest was $31.01 in the past 12 months.
What is Jasper Therapeutics’s market cap?
Currently, no data Available
When is Jasper Therapeutics’s upcoming earnings report date?
Jasper Therapeutics’s upcoming earnings report date is May 10, 2024 which is in 23 days.
How were Jasper Therapeutics’s earnings last quarter?
Jasper Therapeutics released its earnings results on Mar 04, 2024. The company reported -$1.5 earnings per share for the quarter, beating the consensus estimate of -$1.609 by $0.109.
Is Jasper Therapeutics overvalued?
According to Wall Street analysts Jasper Therapeutics’s price is currently Undervalued.
Does Jasper Therapeutics pay dividends?
Jasper Therapeutics does not currently pay dividends.
What is Jasper Therapeutics’s EPS estimate?
Jasper Therapeutics’s EPS estimate is -$1.18.
How many shares outstanding does Jasper Therapeutics have?
Jasper Therapeutics has 15,063,896 shares outstanding.
What happened to Jasper Therapeutics’s price movement after its last earnings report?
Jasper Therapeutics reported an EPS of -$1.5 in its last earnings report, beating expectations of -$1.609. Following the earnings report the stock price went up 0.906%.
Which hedge fund is a major shareholder of Jasper Therapeutics?
Among the largest hedge funds holding Jasper Therapeutics’s share is Woodline Partners LP. It holds Jasper Therapeutics’s shares valued at 14M.
---
Jasper Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$67.50 (179.27% Upside)
$67.50 (179.27% Upside)
Blogger Sentiment
Bullish
JSPR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $7.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 6.6%
Last 30 Days ▲ 6.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.37%
12-Months-Change
Fundamentals
Return on Equity
-112.67%
Trailing 12-Months
Asset Growth
94.96%
Trailing 12-Months
Company Description
Jasper Therapeutics
Amplitude Healthcare Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
---
JSPR Stock 12 Months Forecast
Average Price Target
$67.50
▲(179.27% Upside)
Technical Analysis
BioMarin Pharmaceutical
―
Crispr Therapeutics AG
―
Fate Therapeutics
―
Gilead Sciences
―
Best Analysts Covering JSPR
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+20.09%
reiterated a buy rating 10 months ago
Copying Michael King's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +20.09% per trade.
---